Spruce Biosciences shareholders elect Class III directors at annual meeting

• Spruce Biosciences held its annual shareholder meeting on May 21, 2026.
• Shareholders selected Michael Grey, Camilla V. Simpson, and Javier Szwarcberg to serve as Class III directors through the 2029 annual meeting.
• BDO USA, P.C. was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
• Shareholders backed an annual advisory vote on executive pay frequency, setting the company’s expected cadence through the next required frequency vote by 2032.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spruce Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-239230), on May 26, 2026, and is solely responsible for the information contained therein.